Abstract |
The plasmatic levels of 1,3-beta-d-glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.
|
Authors | Alessandra Mularoni, Elisa Furfaro, Maura Faraci, Alessia Franceschi, Paola Mezzano, Roberto Bandettini, Claudio Viscoli, Elio Castagnola |
Journal | Clinical and vaccine immunology : CVI
(Clin Vaccine Immunol)
Vol. 17
Issue 5
Pg. 882-3
(May 2010)
ISSN: 1556-679X [Electronic] United States |
PMID | 20335432
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Proteoglycans
- beta-Glucans
- polysaccharide-K
|
Topics |
- Aspergillosis
(microbiology, pathology)
- Aspergillus
(isolation & purification)
- Candida
(isolation & purification)
- Candidiasis
(microbiology, pathology)
- Child
- Female
- Fungemia
(pathology)
- Humans
- Immunocompromised Host
- Infant, Newborn
- Male
- Proteoglycans
- beta-Glucans
(blood)
|